50 related articles for article (PubMed ID: 35158070)
1. Relationship between glioblastoma multiforme (GBM) and Alzheimer's disease (AD): is there any reporting bias?
Mokbul MI; Siddik AB
Med Oncol; 2023 Feb; 40(3):101. PubMed ID: 36809382
[No Abstract] [Full Text] [Related]
2. Exploring Gut Microbiota Alterations with Trimethoprim-Sulfamethoxazole and Dexamethasone in a Humanized Microbiome Mouse Model.
Green GBH; Cox-Holmes AN; Backan O; Valbak O; Potier ACE; Chen D; Morrow CD; Willey CD; McFarland BC
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792844
[TBL] [Abstract][Full Text] [Related]
3. An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma.
Stavrakaki E; van den Bossche WBL; Vogelezang LB; Teodosio C; Mustafa DM; van Dongen JJM; Dirven CMF; Balvers RK; Lamfers ML
Cell Rep Methods; 2024 Mar; 4(3):100716. PubMed ID: 38430913
[TBL] [Abstract][Full Text] [Related]
4. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.
Dusoswa SA; Verhoeff J; van Asten S; Lübbers J; van den Braber M; Peters S; Abeln S; Crommentuijn MHW; Wesseling P; Vandertop WP; Twisk JWR; Würdinger T; Noske D; van Kooyk Y; Garcia-Vallejo JJ
Front Immunol; 2024; 15():1343484. PubMed ID: 38318180
[TBL] [Abstract][Full Text] [Related]
5. Prolonged use of temozolomide leads to increased anxiety and decreased content of aggrecan and chondroitin sulfate in brain tissues of aged rats.
Strokotova AV; Sokolov DK; Molodykh OP; Koldysheva EV; Kliver EE; Ushakov VS; Politko MO; Mikhnevich NV; Kazanskaya GM; Aidagulova SV; Grigorieva EV
Biomed Rep; 2024 Jan; 20(1):7. PubMed ID: 38124768
[TBL] [Abstract][Full Text] [Related]
6. CXCR2-Blocking Has Context-Sensitive Effects on Rat Glioblastoma Cell Line Outgrowth (S635) in an Organotypic Rat Brain Slice Culture Depending on Microglia-Depletion (PLX5622) and Dexamethasone Treatment.
Falter J; Lohmeier A; Eberl P; Stoerr EM; Koskimäki J; Falter L; Rossmann J; Mederer T; Schmidt NO; Proescholdt M
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069130
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review.
Asnaashari S; Amjad E; Sokouti B
Cancer Cell Int; 2023 Sep; 23(1):211. PubMed ID: 37743502
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Lipoic Acid, Auraptene, and Particularly Their Combination Prevent the Metastasis of U87 Human Glioblastoma Cells.
Izadi A; Soukhtanloo M; Mirzavi F; Jalili-Nik M; Sadeghi A
Evid Based Complement Alternat Med; 2023; 2023():8618575. PubMed ID: 37496822
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice.
Sokolov DK; Shevelev OB; Khotskina AS; Tsidulko AY; Strokotova AV; Kazanskaya GM; Volkov AM; Kliver EE; Aidagulova SV; Zavjalov EL; Grigorieva EV
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373391
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Steroid and Mannitol Combination Treatment on Postoperative Rehabilitation of Multiple Metacarpal Bone Fractures.
Choi J; Seo HJ; Shin J; Byun JH; Jung SN
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109741
[No Abstract] [Full Text] [Related]
11. Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma Cells.
Keul J; Sperling S; Rohde V; Mielke D; Ninkovic M
Anticancer Res; 2024 May; 44(5):1829-1835. PubMed ID: 38677733
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
Shannon S; Vaca C; Jia D; Entersz I; Schaer A; Carcione J; Weaver M; Avidar Y; Pettit R; Nair M; Khan A; Foty RA
PLoS One; 2015; 10(8):e0135951. PubMed ID: 26284619
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
14. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
[TBL] [Abstract][Full Text] [Related]
15. Advantages and drawbacks of dexamethasone in glioblastoma multiforme.
Afshari AR; Sanati M; Aminyavari S; Shakeri F; Bibak B; Keshavarzi Z; Soukhtanloo M; Jalili-Nik M; Sadeghi MM; Mollazadeh H; Johnston TP; Sahebkar A
Crit Rev Oncol Hematol; 2022 Apr; 172():103625. PubMed ID: 35158070
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies.
Cenciarini M; Valentino M; Belia S; Sforna L; Rosa P; Ronchetti S; D'Adamo MC; Pessia M
Front Mol Neurosci; 2019; 12():65. PubMed ID: 30983966
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
